IL2 and diabetic retinopathy: In our study, Tregs expanded by low-dose IL-2 treatment exhibited increased CLTA-4 and PD-1 in the blood and peripheral lymphoid tissues of mice with OIR or diabetic retinopathy, findings that are consistent with studies of murine atherosclerosis [31] and colitis [32].